Clinical Trial Update: YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating YSPSL to prevent delayed graft function after cadaveric liver transplantation. The current status of the study is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Diseases

Drugs mentioned

• YSPSL

Snippet

Sponsor: Y's Therapeutics, Inc. | Conditions: Liver Diseases | Phase 2 | Status: UNKNOWN